Clavesin 1 anticorps (Middle Region)
Aperçu rapide pour Clavesin 1 anticorps (Middle Region) (ABIN631450)
Antigène
Voir toutes Clavesin 1 (CLVS1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- RLBP1 L1 antibody was raised against the middle region of RLBP1 1
-
Purification
- Affinity purified
-
Immunogène
- RLBP1 L1 antibody was raised using the middle region of RLBP1 1 corresponding to a region with amino acids MFKNFKADDPGIKRALIDGFPGVLENRDHYGRKILLLFAANWDQSRNSFT
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RLBP1L1 Blocking Peptide, (ABIN5615876), is also available for use as a blocking control in assays to test for specificity of this RLBP1L1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RLBP0 1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Clavesin 1 (CLVS1)
-
Autre désignation
- RLBP1L1
-
Sujet
- RLBP1L1 contains 1 CRAL-TRIO domain. It may be used as a marker for human hepatocellular carcinomas.
-
Poids moléculaire
- 41 kDa (MW of target protein)
Antigène
-